Generate Biomedicines, Inc. (GENB)

Generate Biomedicines Statistics

Total Valuation

GENB has a market cap or net worth of $1.57 billion. The enterprise value is $1.39 billion.

Market Cap	1.57B
Enterprise Value	1.39B

Important Dates

The next estimated earnings date is Sunday, May 3, 2026, after market close.

Earnings Date	May 3, 2026
Ex-Dividend Date	n/a

Share Statistics

GENB has 127.45 million shares outstanding.

Current Share Class	127.45M
Shares Outstanding	127.45M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.08%
Owned by Institutions (%)	0.04%
Float	59.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	48.23
Forward PS	n/a
PB Ratio	8.10
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	43.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.85, with a Debt / Equity ratio of 0.36.

Current Ratio	2.85
Quick Ratio	2.69
Debt / Equity	0.36
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-206.92

Financial Efficiency

Return on equity (ROE) is -81.72% and return on invested capital (ROIC) is -42.51%.

Return on Equity (ROE)	-81.72%
Return on Assets (ROA)	-34.63%
Return on Invested Capital (ROIC)	-42.51%
Return on Capital Employed (ROCE)	-94.79%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$102,221
Profits Per Employee	-$799,753
Employee Count	312
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

In the past 12 months, GENB has paid $163,000 in taxes.

Income Tax	163,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	50.92
Average Volume (20 Days)	1,141,083

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GENB had revenue of $31.89 million and -$249.52 million in losses. Loss per share was -$4.98.

Revenue	31.89M
Gross Profit	-192.81M
Operating Income	-235.07M
Pretax Income	-222.80M
Net Income	-249.52M
EBITDA	-221.89M
EBIT	-235.07M
Loss Per Share	-$4.98

Balance Sheet

The company has $221.50 million in cash and $68.53 million in debt, with a net cash position of $152.97 million or $1.20 per share.

Cash & Cash Equivalents	221.50M
Total Debt	68.53M
Net Cash	152.97M
Net Cash Per Share	$1.20
Equity (Book Value)	189.83M
Book Value Per Share	-12.24
Working Capital	152.16M

Cash Flow

In the last 12 months, operating cash flow was -$200.62 million and capital expenditures -$3.51 million, giving a free cash flow of -$204.13 million.

Operating Cash Flow	-200.62M
Capital Expenditures	-3.51M
Free Cash Flow	-204.13M
FCF Per Share	-$1.60

Margins

Gross Margin	n/a
Operating Margin	-737.04%
Pretax Margin	-698.59%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GENB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-16.22%
FCF Yield	-13.27%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GENB has an Altman Z-Score of -4.57 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.57
Piotroski F-Score	1